Awardee will study the role the immune system plays in Parkinson’s disease
The Pew Charitable Trusts has announced that Eunice A. Domínguez-Martín, Ph.D., an NIH post-doctoral fellow, is one of 10 recipients of an award from Pew’s Latin American Fellows Program in Biomedical Sciences. Every year the program awards “10 of Latin America’s brightest biomedical researchers for postdoctoral training in the U.S.” This includes a $30,000 per year annual salary stipend for two years and an additional $70,000 grant for equipment and supplies to recipients who return to Latin America as independent investigators.
Dr. Domínguez-Martín works in the laboratory of Richard J. Youle, Ph.D., senior investigator at the NIH’s National Institute of Neurological Disorders and Stroke, where she is currently conducting pre-clinical research on the role the innate immune system may play in damaging the brain during Parkinson’s disease. Originally from Mexico, Dr. Domínguez-Martín has a bachelor’s degree in basic biomedical research and a master’s degree in biochemistry from the National Autonomous University of Mexico (UNAM). In 2018, she earned a joint Ph.D. in biomedical research from UNAM and in Molecular Biosciences from the Autonomous University of Madrid in Spain. Before joining the NIH, Dr. Domínguez-Martín primarily studied the chemical reactions behind a cell’s response to stress, including the accumulation of misfolded proteins.
For more information:
NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit the NIH website.